Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Who is the clown who can't read a prepared statement?

<< Previous

Bullboard Posts

Next >>

Comment by consultant99on Jun 19, 2024 10:02pm

204 Views

Post# 36097155

RE:RE:RE:RE:Who is the clown who can't read a prepared statement?

I agree. A convertible debenture with a 5 year term, interest paid at the end and af proviso of converting the debt to shares at a significant premium to the market price I think would have secured finacing until after FDA appoval.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments